Paris, France, May 23, 2026
Streetlab, a premier R&D service company dedicated to advanced real-life functional vision exploration for the visually impaired, is proud to highlight its long-standing and successful made-to-order R&D service collaboration with Johnson & Johnson Medtech Vision (« J&J » or « Johnson & Johnson»). This collaboration culminates in significant clinical findings to be presented at the Association for Research in Vision and Ophthalmology (ARVO) 2026 annual meeting in Denver, USA.
A service model rooted in unique expert innovation
This service-based collaboration began when Johnson & Johnson approached Streetlab for its unique expertise and “one-of-a-kind” ecosystem in assessing functional vision. Streetlab, founded in 2011 as a spin-off service company from the Institut de la Vision, has acted as an R&D service provider, leveraging its multidisciplinary team of researchers, engineers, and clinical specialists to design tailored testing protocols and solutions to support J&J’s innovations in intraocular lenses.
Over the years, this relationship has matured into a powerful engine for clinical validation. By utilizing Streetlab’s specialized platforms – most notably its state-of-the-art driving simulator – Johnson & Johnson has successfully demonstrated the functional benefits that optical improvements in lens designs bring to daily life activities such as driving.The partnership’s effectiveness is underscored by two major presentations at ARVO.
“Our collaboration with Johnson & Johnson is a testament to the power of combining industry-leading medical technology with Streetlab’s specialized behavioral measurement tools for functional vision,” says Julien Adrian, Researcher. “Seeing our functional scenarios translate into validated clinical endpoints that directly impact patient safety and autonomy is a point of immense pride for our team.”
“Streetlab’s ability to design custom functional testing and to simulate complex, real-world environments like urban driving allows our partners to move beyond traditional eye exams,” adds Colas Authié, Head of Science and Innovation. “We provide the objective data needed to prove a treatment’s true therapeutic benefit.”
Streetlab’s outlook: accelerating the future of ophthalmology
Streetlab is committed to accelerating the journey from medical innovation to market maturity. Having demonstrated a repeatable, high-impact R&D model for global leaders in pharma and medtech like J&J, Streetlab is now open for collaborations with other industrial innovators. We offer a unique capability to design de novo, tailor-made functional evaluation protocols across multiple eye disease segments. For companies seeking to validate their solutions through objective, standardized, and real-world performance metrics, Streetlab provides the definitive platform for functional proof-of-concept.
About Streetlab
Founded in 2011, Streetlab is a world-class R&D innovation hub and service company dedicated to the objective assessment of functional vision. Our core mission is to quantify the real-life performance of visually impaired individuals during daily tasks, providing the robust, standardized data essential for evaluating innovative solutions and assessing therapeutic benefits.
Streetlab has pioneered a suite of cutting-edge digital assessment tools that have become benchmarks in ophthalmic research:
- MOST-VR: Our flagship immersive platform for measuring disease progression and therapeutic efficacy in inherited retinal diseases. Scientifically validated for its repeatability and sensitivity, MOST-VR is a globally-ready solution currently deployed in 43 systems across 35 sites in 11 countries, spanning the US, Europe, Australia, and Brazil.
- SPOT & VR-ViSA: Specialized virtual reality environments designed to evaluate visual search performance and object recognition capabilities. These tools allow for the immersion of patients in controlled, reproducible conditions with state-of-the-art behavioral measurements.
A Strategic Partner for Clinical Success With over 17 years of expertise in behavioral analysis, Streetlab has a proven track record of conducting 38 clinical studies (Phases I–IV) and evaluating 91 unique products. Our technology is trusted by leading pharmaceutical, biotech, and medtech companies to drive product differentiation and support functional claims through objective performance metrics. By bridging the gap between traditional eye exams and real-world autonomy, Streetlab accelerates the delivery of life-changing innovations to patients.
Business contact:
Marco Lombardi, MD
marco.lombardi@streetlab-vision.com